E
eXoZymes, Inc. (EXOZ)
NCM – Real Time Price. Currency in USD
9.88
+0.08 (0.82%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
9.88
+0.08 (0.82%)
At close: May 12, 2026, 4:00 PM EDT
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
| Name | Position |
|---|---|
| Dr. Paul Opgenorth Ph.D. | Co-Founder & Vice President of Development |
| Dr. Tyler Korman Ph.D. | Co-Founder & Chief Scientific Officer |
| Mr. Damien A. Perriman | Chief Commercial Officer |
| Mr. Fouad Nawaz | Vice President of Finance |
| Mr. James U. Bowie Ph.D. | Founder & Independent Director |
| Mr. Lasse H. Gorlitz | Vice President of Communications |
| Mr. Michael Burns | Executive Vice President of Energy Transition |
| Mr. Michael Heltzen | President & CEO |
| Ms. Amy Lunzer | Chief of Staff |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | form8-k.htm |
| 2026-04-10 | 8-K | form8-k.htm |
| 2026-03-31 | 8-K | form8-k.htm |
| 2026-03-30 | 10-K | form10-k.htm |
| 2026-02-05 | 8-K | form8-k.htm |
| 2026-01-16 | S-3 | forms-3.htm |
| 2025-12-16 | S-8 | forms-8.htm |
| 2025-12-15 | DRS | filename1.htm |
| 2025-12-12 | 8-K | form8-k.htm |
| 2025-11-13 | 8-K | form8-k.htm |